Table 3 Frequency of adverse events in the two groups
Adverse events | Treatment group | ||||
|---|---|---|---|---|---|
granisetron + sertraline | placebo + sertraline |  | |||
N | % | N | % | p-value | |
Muscle pain | 1 | 3.7 | 0 | 0 | 0.99 |
Headache | 1 | 3.7 | 0 | 0 | 0.99 |
Diarhea | 0 | 0 | 1 | 4.8 | 0.43 |
Constipation | 1 | 3.7 | 0 | 0 | 0.99 |
Decreased libido | 3 | 11.1 | 1 | 4.8 | 0.62 |
Decreased appetite | 1 | 3.7 | 0 | 0 | 0.99 |
Lightheadness | 1 | 3.7 | 1 | 4.8 | 0.99 |
Tremor | 1 | 0 | 0 | 0 | 0.99 |
Skin lesions | 1 | 0 | 0 | 0 | 0.99 |
Motor tic | 0 | 0 | 1 | 4.8 | 0.43 |
Palpitation | 1 | 3.7 | 0 | 0 | 0.99 |
Insomnia | 2 | 7.4 | 1 | 4.8 | 0.99 |
Itching | 0 | 0 | 1 | 4.8 | 0.43 |
Restlesness | 0 | 0 | 1 | 4.8 | 0.43 |
Vomiting | 1 | 3.7 | 0 | 0 | 0.99 |